Dr. Stout has over 25 years of biopharmaceutical development and large scale biologics manufacturing experience. Dr. Stout joined SanBio in 2016. Prior to joining SanBio, Dr. Stout was Executive Director and Distinguished Scientist in the Center for Biopharmaceutical Manufacturing Sciences at Merck from 2008-2016. At Merck, Dr. Stout successfully licensed the first immune-oncology product, Keytruda, in the United States. Prior to Merck, Dr. Stout held positions of increasing responsibility at biopharmaceutical companies including Amgen, Pfizer, and BioNebraska (Restoragen). Dr. Stout has been involved in the scale up, technology transfer, and licensure of more than ten biologics products in more than twenty manufacturing facilities. Dr. Stout has a PhD in Chemistry and Biochemistry from the University of Nebraska-Lincoln and MS and BS in Chemistry from the University of Iowa.